Image may be NSFW.
Clik here to view.
Clik here to view.
SemBioSys receives U.S. patent for plant apoliprotein
SemBioSys Genetics (TSX:SBS) has received a U.S. patent for the “Methods for the Production of Apolipoproteins in Transgenic Plants,” which is key to successfully commercializing plant-made and...
View Article
Image may be NSFW.
Clik here to view.
Clik here to view.
Ciclofilin developing first drug for HCV/HIV-1 co-infection
Closely held Ciclofilin Pharmaceuticals is developing what, it hopes, will be the first clinically effective treatment for hepatitis C virus (HCV)/HIV-1 co-infection, with specific antiviral activity...
View Article
More Pages to Explore .....
